Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B N Savani

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|November 3, 2010
Outcome, toxicity profile and cost analysis of autologous stem cell mobilizationM H Jagasia, B N Savani, A Neff, et al.
Bone Marrow Transplantation|August 8, 2017
Is there any role for physical therapy in chronic GvHD?J Mohammed, B N Savani, A El-Jawahri, et al.
Bone Marrow Transplantation|February 14, 2012
Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphomaN Reddy, J P Greer, S Goodman, et al.
Bone Marrow Transplantation|April 4, 2017
Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?M A Kharfan-Dabaja, N El-Jurdi, E Ayala, et al.
Bone Marrow Transplantation|July 20, 2007
Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplantB P Soule, N L Simone, B N Savani, et al.
Bone Marrow Transplantation|October 8, 2013
Six-month freedom from treatment failure is an important end point for acute GVHD clinical trialsS Sengsayadeth, B N Savani, M Jagasia, et al.
Leukemia|June 13, 2008
Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapyA S M Yong, K Keyvanfar, R Eniafe, et al.
Bone Marrow Transplantation|April 5, 2016
Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivorsP Anandi, N A Jain, X Tian, et al.
Bone Marrow Transplantation|June 14, 2016
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMTP Tsirigotis, M Byrne, C Schmid, et al.
Leukemia|January 22, 2011
Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 proteinA S M Yong, N Stephens, G Weber, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|November 3, 2010
Outcome, toxicity profile and cost analysis of autologous stem cell mobilizationM H Jagasia, B N Savani, A Neff, et al.
Bone Marrow Transplantation|August 8, 2017
Is there any role for physical therapy in chronic GvHD?J Mohammed, B N Savani, A El-Jawahri, et al.
Bone Marrow Transplantation|February 14, 2012
Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphomaN Reddy, J P Greer, S Goodman, et al.
Bone Marrow Transplantation|April 4, 2017
Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?M A Kharfan-Dabaja, N El-Jurdi, E Ayala, et al.
Bone Marrow Transplantation|July 20, 2007
Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplantB P Soule, N L Simone, B N Savani, et al.
Bone Marrow Transplantation|October 8, 2013
Six-month freedom from treatment failure is an important end point for acute GVHD clinical trialsS Sengsayadeth, B N Savani, M Jagasia, et al.
Leukemia|June 13, 2008
Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapyA S M Yong, K Keyvanfar, R Eniafe, et al.
Bone Marrow Transplantation|April 5, 2016
Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivorsP Anandi, N A Jain, X Tian, et al.
Bone Marrow Transplantation|June 14, 2016
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMTP Tsirigotis, M Byrne, C Schmid, et al.
Leukemia|January 22, 2011
Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 proteinA S M Yong, N Stephens, G Weber, et al.
Pageof 6